Actively Recruiting
Evaluating the Turkish Version of the Severe Respiratory Insufficiency Questionnaire for Home Non-Invasive Ventilation Patients
Led by Istanbul Saglik Bilimleri University · Updated on 2026-11-04
120
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the Turkish version of the Severe Respiratory Insufficiency Questionnaire for Non-Invasive Ventilation S3-NIV to determine its reliability and validity in patients using home non-invasive ventilation NIV. This questionnaire is designed to assess difficulties and compliance among patients with chronic respiratory failure who use home NIV. The study involves 120 stable patients who have been using home NIV for at least three months across multiple centers. Participants will complete an 11-item Turkish S3-NIV questionnaire along with a sociodemographic and clinical data form. To assess test-retest reliability, a subgroup of 40 patients will retake the questionnaire 14 to 15 days after the first completion. The study will analyze internal consistency, construct validity through factor analysis, and criterion validity by correlating questionnaire results with clinical parameters such as daily NIV usage and blood gas values. During the study, participants will provide information through the questionnaires at baseline and for some, again after two weeks. Researchers will evaluate the consistency and validity of the questionnaire results and assess how well it reflects clinical measures. The total study duration extends until August 2027, with ongoing monitoring of patients responses and clinical data to ensure accurate evaluation of the questionnaires properties.
CONDITIONS
Brief Title
Validation of the Turkish Version of the S3-NIV Questionnaire
Research Team
D
Dilek Unsal, PT PhD(c)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here